H.C. Wainwright has reiterated its stock rating of 'buy' for Madrigal Pharmaceuticals.
The rating comes amid discussions regarding the company's performance, with Madrigal stating, 'I Can't Bet Against A Company Performing This Well.'
H.C. Wainwright reiterates buy rating for Madrigal Pharmaceuticals
The investment firm maintains its positive outlook on the company following recent performance.
AlphaTradeZone
Sources 2
Spotted an error?
Report a correction.
